Vet Medicine: Longevity Pills, Vet Shortages and Bills — 2026-09-27
This week, the UK's CMA vet remedies formally became a legal Order on 22 September 2026, starting compliance deadlines for the £21 prescription fee cap and published price lists. In the US, attention turns to rising pet insurance costs, rural veterinary shortages, and Loyal's STAY longevity trial moving toward a second FDA-supported canine lifespan drug. German-language press continues to scrutinize emergency vet fees under the GOT fee schedule.
Vet Medicine: Longevity Pills, Vet Shortages and Bills — 2026-09-27
Top developments
CMA vet remedies become a legal Order — compliance clocks now running
The CMA's vets market remedies became a legal Order on 22 September 2026, kicking off compliance timelines for the £21 prescription fee cap, published price lists, written estimates and itemised bills. The first stage of the reforms — clear pricing for pet owners — is expected to be fully legally binding by December. This matters for anyone tracking vet corporate chains and affordability, as it is the first hard legal deadline in the UK competition crackdown.
Rising pet insurance premiums in focus as owners seek workarounds
A 25 September analysis examines how vet bills keep climbing and what actually drives pet insurance pricing, offering four practical ways owners can cover rising costs without draining savings. The piece reflects the growing affordability squeeze that has defined the US pet insurance market this year. It matters as insurers face mounting pressure over renewal hikes and coverage gaps.
Rural America's vet shortage deepens in North Dakota
Local reporting from Minot (published 23 September) describes how rural counties across the US face a growing shortage of veterinary practices, driven by a surge in pet ownership, too few new graduates, retirements, burnout and economic pressure — resulting in long waits, limited services and higher costs. The shortage directly pushes bills upward and constrains access to new treatments.
Loyal's second canine longevity drug gets FDA support; STAY study continues
dvm360 reported this week that a second drug for canine healthy lifespan extension has received FDA support, with the STAY study — the first and only FDA-concurred clinical trial for longevity and, per Loyal, the largest veterinary trial in history — running across many clinical-trial-naïve vet clinic sites. The first dog was dosed in December 2023, and the sister LOY-002 trial completed its 1,000-dog enrollment target in August 2026. This keeps momentum behind the dog longevity pill category approaching potential approval.
Local view
German consumer-legal outlet Rechtstipps.net (26 September) reminds pet owners they can challenge inflated invoices: vets bill under the GOT fee schedule at one to three times the standard rate, and up to four times plus a €50 surcharge for out-of-hours emergency service — and bills above this may be excessive.
German dog-owner magazine honestdog.de (mid-September) covers what owners "really pay at night" for emergency vet service fees, amid an ongoing dispute over GOT rates that, it says, is worsening staffing shortages in practices.
Context & numbers
- UK prescription fee cap: £21 per vet prescription, with vets required to disclose cheaper medicine options — compliance timelines began with the 22 September Order.
- Example US insurance premium benchmarks: Trupanion ~$45/month ($540/year, 90% reimbursement, $200 deductible) vs Pets Best ~$35/month ($420/year).
- German billing limits: 1x–3x GOT standard rate for routine care; up to 4x plus €50 out-of-hours emergency allowance.
On the radar
- December 2026: deadline for the first stage of UK CMA reforms (clear pricing, price lists, itemised bills) to be fully legally binding.
- Vets have one year to implement the UK prescription fee cap — watch for implementation enforcement through 2027.
- Loyal's LOY-002 and the STAY study's progress toward a potential launch remains the rumor-adjacent watch item for the dog longevity pill market; industry chatter points to a 2026–2027 launch window, but nothing has been confirmed this week.
- Annual SPVS salary survey in the UK is open to vets, nurses and practice teams — results will feed the next round of workforce data.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
